Goto K - Search Results

1

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.

Drilon A, Siena S, Dziadziuszko R, Barlesi F, Krebs MG, Shaw AT, de Braud F, Rolfo C, Ahn MJ, Wolf J, Seto T, Cho BC, Patel MR, Chiu CH, John T, Goto K, Karapetis CS, Arkenau HT, Kim SW, Ohe Y, Li YC, Chae YK, Chung CH, Otterson GA, Murakami H, Lin CC, Tan DSW, Prenen H, Riehl T, Chow-Maneval E, Simmons B, Cui N, Johnson A, Eng S, Wilson TR, Doebele RC; trial investigators. Drilon A, et al. Among authors: goto k. Lancet Oncol. 2020 Feb;21(2):261-270. doi: 10.1016/S1470-2045(19)30690-4. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838015 Free PMC article.

2

Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer.

Niho S, Ohe Y, Kakinuma R, Kubota K, Matsumoto T, Ohmatsu H, Goto K, Nishiwaki Y. Niho S, et al. Among authors: goto k. Lung Cancer. 2002 Feb;35(2):209-14. doi: 10.1016/s0169-5002(01)00328-2. Lung Cancer. 2002. PMID: 11804695 Clinical Trial.

3

Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.

Niho S, Kubota K, Goto K, Ohmatsu H, Matsumoto T, Kakinuma R, Nishiwaki Y. Niho S, et al. Among authors: goto k. Cancer Chemother Pharmacol. 2003 Jul;52(1):19-24. doi: 10.1007/s00280-003-0618-8. Epub 2003 Apr 24. Cancer Chemother Pharmacol. 2003. PMID: 12712259 Clinical Trial.

4

Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.

Yoh K, Ishii G, Yokose T, Minegishi Y, Tsuta K, Goto K, Nishiwaki Y, Kodama T, Suga M, Ochiai A. Yoh K, et al. Among authors: goto k. Clin Cancer Res. 2004 Mar 1;10(5):1691-7. doi: 10.1158/1078-0432.ccr-0937-3. Clin Cancer Res. 2004. PMID: 15014021

5

Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.

Niho S, Ohe Y, Goto K, Ohmatsu H, Matsumoto T, Kubota K, Kakinuma R, Nishiwaki Y. Niho S, et al. Among authors: goto k. Jpn J Clin Oncol. 2004 Feb;34(2):69-73. doi: 10.1093/jjco/hyh019. Jpn J Clin Oncol. 2004. PMID: 15067098 Clinical Trial.

6

A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC).

Ishikura S, Ohe Y, Nihei K, Kubota K, Kakinuma R, Ohmatsu H, Goto K, Niho S, Nishiwaki Y, Ogino T. Ishikura S, et al. Among authors: goto k. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1117-22. doi: 10.1016/j.ijrobp.2004.07.692. Int J Radiat Oncol Biol Phys. 2005. PMID: 15752891 Clinical Trial.

7

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study.

Niho S, Kubota K, Goto K, Yoh K, Ohmatsu H, Kakinuma R, Saijo N, Nishiwaki Y. Niho S, et al. Among authors: goto k. J Clin Oncol. 2006 Jan 1;24(1):64-9. doi: 10.1200/JCO.2005.02.5825. J Clin Oncol. 2006. PMID: 16382114 Clinical Trial.

8

A review of the benefit-risk profile of gefitinib in Asian patients with advanced non-small-cell lung cancer.

Park K, Goto K. Park K, et al. Among authors: goto k. Curr Med Res Opin. 2006 Mar;22(3):561-73. doi: 10.1185/030079906X89847. Curr Med Res Opin. 2006. PMID: 16574039 Review.

9

Eg5 expression is closely correlated with the response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy.

Saijo T, Ishii G, Ochiai A, Yoh K, Goto K, Nagai K, Kato H, Nishiwaki Y, Saijo N. Saijo T, et al. Among authors: goto k. Lung Cancer. 2006 Nov;54(2):217-25. doi: 10.1016/j.lungcan.2006.06.018. Epub 2006 Aug 24. Lung Cancer. 2006. PMID: 16934364

10

Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy.

Yoh K, Kubota K, Kakinuma R, Ohmatsu H, Goto K, Niho S, Saijo N, Nishiwaki Y. Yoh K, et al. Among authors: goto k. Lung Cancer. 2007 Oct;58(1):73-9. doi: 10.1016/j.lungcan.2007.04.015. Epub 2007 Jun 4. Lung Cancer. 2007. PMID: 17548127 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,631 results

Search Page